Search

everythinglearnresearchcommunity

for

Search:↓

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

CXCL12 protein slows down hair growth through its receptor CXCR4. Blocking this can potentially increase hair growth.

A new cosmetic cream reduced facial redness and skin temperature after 4 weeks of use.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

Immunomodulatory therapies are effective for treating cutaneous lymphoma, particularly in early stages.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

Using methods like lasers and microneedling with drugs can improve hair regrowth for alopecia, but more research is needed on safety and best practices.

TNF-alpha inhibitors can cause various immune-related skin issues.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

The most common cause of hair loss in children is tinea capitis, followed by alopecia areata and telogen effluvium.

Methotrexate improved skin condition in 64% of patients with generalized granuloma annulare.

Stopping adalimumab and starting methotrexate with topical treatments improved the woman's scalp psoriasis and hair regrew.

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Most patients with rheumatoid arthritis continued methotrexate treatment over two years, but those who stopped and restarted experienced more side effects and less improvement.

A young woman had a rare skin reaction to a medication for her joint disease, and a combination therapy improved her condition.

Tofacitinib citrate is effective for moderate-to-severe chronic plaque psoriasis but has safety concerns at higher doses.

UK medical students lack dermatology education, liver biopsy patients with risk factors show more fibrosis, and certain fungi resist drugs due to melanin; genetics may influence female hair loss.

Dupilumab for eczema may cause hair loss.

JAK inhibitors, like baricitinib, are effective and safe for treating alopecia areata.

Finasteride helped treat a 28-year-old's facial skin condition.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

Secukinumab can cause hair loss, which may improve after stopping the medication.

Anti-IL-12/IL-23 antibody therapy effectively treats psoriasiform skin lesions in IBD patients.

Endocrine therapies for cancer significantly increase the risk of hair loss.

Jojoba oil is highly valued for its diverse medicinal and industrial uses.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.